pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 1
vobramitamab tavatecan
vobramitamab tavatecan[INN]
Bladder Cancer
$MGNXMACROGENICS INC
0 catalysts
Phase 2
vodobatinib
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Tyrosine-protein kinase ABL1Bcr/Abl fusion protein
Sun Pharma Advanced Research Company Ltd
0 catalysts
Phase 2
vopimetostat
vopimetostat [INN]
Bladder Cancer
← prev
page 61 of 62
next →
131
Pain89
Neurology1
$TNGXTango Therapeutics, Inc.
0 catalysts
Marketed
vorasidenib citrate
Voranigo (vorasidenib citrate)
Low-Grade Glioma
Les Laboratoires Servier SAS
0 catalysts
Marketed
vorinostat
Zolinza (vorinostat)
Cutaneous T-Cell Lymphoma
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
vosilasarm
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Ellipses Pharma Ltd
0 catalysts
Phase 2
vusolimogene oderparepvec
Basal Cell Carcinoma (Basal Cell Epithelioma)
$REPLReplimune Group, Inc.
0 catalysts
Phase 3
xaluritamig
xaluritamig [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$AMGNAMGEN INC
0 catalysts
Phase 1
xirestomig
xirestomig [INN]
Non-Hodgkin Lymphoma
Antengene Corp Ltd
0 catalysts
Phase 2
zabilugene almadenorepvec
Pancreatic Ductal Adenocarcinoma
$TOVXTheriva Biologics, Inc.
0 catalysts
Phase 2
zalifrelimab
Cervical Cancer
Cytotoxic T-lymphocyte protein 4
$AGENAGENUS INC
0 catalysts
Phase 1
zaloblideg
zaloblideg [INN]
Diffuse Large B-Cell Lymphoma
$ARVNARVINAS, INC.
0 catalysts
pre_registration
zanidatamab
Ziihera (zanidatamab-hrii)
Adenocarcinoma Of The Gastroesophageal Junction
Receptor tyrosine-protein kinase erbB-2
$JAZZJazz Pharmaceuticals plc
0 catalysts
pre_registration
zanzalintinib fumarate
Metastatic Colorectal Cancer
$EXELEXELIXIS, INC.
0 catalysts
Phase 1
zavondemstat
zavondemstat [INN]
Gastrointestinal Tumor
Tachyon Therapeutics Inc
0 catalysts
Phase 1
zelebrudomide
Diffuse Large B-Cell Lymphoma
$NRIXNurix Therapeutics, Inc.
0 catalysts
Phase 2
zelenirstat
zelenirstat [INN]
Refractory Acute Myeloid Leukemia
Pacylex Pharmaceuticals Inc
0 catalysts
pre_registration
zenocutuzumab
Bizengri (zenocutuzumab-zbco)
Bile Duct Cancer (Cholangiocarcinoma)
ErbB-2/ErbB-3 heterodimer
Merus NV
0 catalysts
pre_registration
zidesamtinib
Non-Small Cell Lung Cancer
$NUVLNuvalent, Inc.
0 catalysts
Marketed
ziftomenib
Komzifti (ziftomenib)
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$KURAKura Oncology, Inc.
0 catalysts
Phase 2
zilovertamab vedotin
zilovertamab vedotin [INN]
Mantle Cell Lymphoma
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
zilurgisertib fumarate
Fibrodysplasia Ossificans Progressiva (Myositis Ossificans Progressiva)
$INCYINCYTE CORP
0 catalysts
Phase 2
zimberelimab
Adenocarcinoma Of The Gastroesophageal Junction
Programmed cell death protein 1
$RCUSArcus Biosciences, Inc.
0 catalysts
pre_registration
zipalertinib
Non-Small Cell Lung Cancer
Epidermal growth factor receptor
Taiho Pharmaceutical Co Ltd
0 catalysts
Marketed
ziv-aflibercept
Zaltrap (ziv-aflibercept [INN])
Metastatic Colorectal Cancer
Sanofi-Aventis US LLC
0 catalysts
Phase 3
zocilurtatug pelitecan
Small-Cell Lung Cancer
$ZLABZai Lab Ltd
0 catalysts
Phase 2
zolbetuximab
Vyloy (zolbetuximab-clzb)
Metastatic Adenocarcinoma of The Pancreas
Claudin-18
Astellas Pharma Inc
0 catalysts
Phase 2
zolucatetide
zolucatetide [INN]
Craniopharyngioma
Parabilis Medicines
0 catalysts
Phase 2
zotiraciclib citrate
Glioblastoma Multiforme (GBM)
Beijing zhikangbo Medical Oncology Research Co Ltd
0 catalysts
Phase 3
zovegalisib
zovegalisib [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$RLAYRelay Therapeutics, Inc.
0 catalysts